Keyphrases
Black South African Patients
100%
Type 2 Diabetic Patients
100%
Advanced Glycation End Products
100%
Type 2 Diabetes Mellitus (T2DM)
75%
Carboxymethyllysine
50%
Fluorescent AGEs
50%
Endothelial Dysfunction
50%
Serum Levels
50%
Race Groups
50%
N-carboxymethyllysine
37%
Non-diabetic
37%
Lysine Level
25%
Markers of Endothelial Dysfunction
25%
Product Level
25%
Negatively Associated
20%
Black South Africans
20%
Academic Hospital
20%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Lysine
12%
Fluorescent Advanced Glycation End Products (fAGEs)
12%
Pretoria
12%
South Africa
12%
Nitric Oxide Level
8%
Spearman Correlation Coefficient
8%
Black Men
8%
Serum Markers
8%
Immunogenic
8%
Diabetic Subjects
8%
Logistic Regression Analysis
8%
Plasma Markers
8%
Bivariate Logistic Regression
8%
Medicine and Dentistry
Advanced Glycation End-Product
50%
Patient with Type 2 Diabetes
50%
Endothelial Dysfunction
50%
6 N Carboxymethyllysine
50%
Maturity Onset Diabetes of the Young
50%
Enzyme Linked Immunosorbent Assay
12%
Logistic Regression Analysis
6%
Case-Control Study
6%
Nitric Oxide
6%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Dysfunction
50%
Advanced Glycation End Product
50%
6 N Carboxymethyllysine
50%
Non Insulin Dependent Diabetes Mellitus
50%
Enzyme-Linked Immunosorbent Assay
12%
Case-Control Study
6%
Nitric Oxide
6%
